Cargando…
Novel agents and biomarkers for acute lymphoid leukemia
New genetic markers for adult acute lymphoblastic leukemia (ALL) have been found to have prognostic impact, such as the lymphoid transcription factor gene IKZF1 alterations, which are associated with a high rate of leukemic relapse in B-ALL. Although complete remission rates by induction chemotherap...
Autores principales: | Zhao, Yanmin, Huang, He, Wei, Guoqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3718656/ https://www.ncbi.nlm.nih.gov/pubmed/23773228 http://dx.doi.org/10.1186/1756-8722-6-40 |
Ejemplares similares
-
Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemia
por: Wei, Guoqing, et al.
Publicado: (2017) -
Novel Agents for Acute Myeloid Leukemia
por: Luppi, Mario, et al.
Publicado: (2018) -
New agents for the treatment of lymphoid leukemia and lymphoma: focus on recent FDA approvals
por: Stancu, Andreea Lucia, et al.
Publicado: (2014) -
Unraveling the Role of Innate Lymphoid Cells in Acute Myeloid Leukemia
por: Lordo, Matthew R., et al.
Publicado: (2021) -
Frontline therapies for untreated chronic lymphoid leukemia
por: Liu, Delong, et al.
Publicado: (2019)